Capital Fund Management S.A. Penumbra Inc Transaction History

Capital Fund Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$153.32 - $191.72 $627,385 - $784,518	-4,092 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$124.34 - $193.76 $508,799 - $792,865	4,092 New	4,092 $660,000
Q2 2019 Aug 12, 2019	SELL	$124.65 - $167.39 $361,485 - $485,430	-2,900 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$115.84 - $160.31 $335,936 - $464,899	2,900 New	2,900 $426,000
Q4 2018 Feb 13, 2019	SELL	$113.42 - $156.48 $215,498 - $297,312	-1,900 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$121.55 - $156.8 $3.89 Million - $5.02 Million	-32,000 Reduced 94.4%	1,900 $284,000
Q2 2018 Aug 14, 2018	BUY	$112.2 - $165.95 $3.8 Million - $5.63 Million	33,900 New	33,900 $4.68 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.